| Print
DIASORIN (DIA)
DIASORINThis share can be held in a Dealing accountSIPP
Company profile
Diasorin develops and manufactures a broad portfolio of in vitro diagnostics used for detecting pathogens and contamination of samples from the human body, as well as used in industrial settings such as food and water contamination testing. The company operates three segments: immunodiagnostics (66% of sales), molecular diagnostics (17%), and licensed technologies (14%). Diasorin was an important manufacturer of covid tests, which boosted its profits during the pandemic, but this segment's importance has decreased over the years, and in 2024, it accounted for only 2% of total sales.
Address
via Crescentino snc.
Saluggia (Vercelli)
ITA
13040
Telephone
+39 161487964
Forecast key dates
| Name | Key Date |
|---|---|
| Diasorin SpA Third Quarter Earnings Conference Call for 2026 | 2026-11-05T18:00:00 |
| Diasorin SpA Third Quarter Earnings Results for 2026 | 2026-11-05T00:00:00 |
| Diasorin SpA Second Quarter Earnings Conference Call for 2026 | 2026-07-31T17:00:00 |
| Diasorin SpA Second Quarter Earnings Results for 2026 | 2026-07-31T00:00:00 |
| Diasorin SpA First Quarter Earnings Conference Call for 2026 | 2026-05-06T18:00:00 |
| Diasorin SpA First Quarter Earnings Results for 2026 | 2026-05-06T00:00:00 |
| Diasorin SpA Annual General Meeting for 2026 | 2026-04-28T15:00:00 |
| Diasorin SpA Annual Report for 2025 | 2026-04-03T00:00:00 |
| Diasorin SpA Fourth Quarter Earnings Conference Call for 2025 | 2026-03-13T16:30:00 |
| Diasorin SpA Fourth Quarter Earnings Results for 2025 | 2026-03-13T00:00:00 |
Previous key dates
| Name | Key Date |
|---|---|
| Diasorin SpA Third Quarter Earnings Conference Call for 2025 | 2025-11-05T18:00:00 |
| Diasorin SpA Third Quarter Earnings Result for 2025 | 2025-11-05T00:00:00 |
| Diasorin SpA Second Quarter Earnings Conference Call for 2025 | 2025-07-31T17:00:00 |
| Diasorin SpA Second Quarter Earnings Result for 2025 | 2025-07-31T00:00:00 |
| Diasorin SpA First Quarter Earnings Conference Call for 2025 | 2025-05-06T18:00:00 |
| Diasorin SpA First Quarter Earnings Results for 2025 | 2025-05-06T00:00:00 |
| Diasorin SpA Annual General Meeting for 2025 | 2025-04-28T15:00:00 |
| Diasorin SpA Annual Report for 2024 | 2025-04-04T00:00:00 |
| Diasorin SpA Fourth Quarter Earnings Conference Call for 2024 | 2025-03-14T16:30:00 |
| Diasorin SpA Fourth Quarter Earnings Result for 2024 | 2025-03-14T00:00:00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2026 AJ Bell. All rights reserved.